2026-05-15T11:30:56-04:00 2025-06-30 660388756 RSM PUERTO RICO PO BOX 10528 SAN JUAN PR 009220528 990 2024-07-01 660856773 PUERTO RICO CONSORTIUM FOR CLINICAL INVESTIGATION INC PUER 7875231592 PO BOX 363475 SAN JUAN PR 00901 AMARILYS SIVA BOSCHETTI EXECUTIVE DIRECTOR 7875231592 2026-05-15 true false RAFAEL DE ROJAS SANCHEZ P01034935 7877516164 2026-05-15 2024 2025-03-06 01:10:19Z AMARILYS SIVA BOSCHETTI PO BOX 363475 SAN JUAN AF 00901 1736630 false X X DATA, SCIENCE AND CLINICAL INVESTIGATION. NOT FOR PROFIT COOPERATIVE OF TOP ACADEMIC AND PRIVATE RESEARCH SITES. 7 7 18 0 334548 1385640 0 0 1219108 350990 1553656 1736630 0 0 1131309 1209894 0 0 632669 588702 1763978 1798596 -210322 -61966 657430 622005 241357 267898 416073 354107 X PURPOSE OF THE NFP DEVELOP RESEARCH AND CLINICAL INVESTIGATION. false false 1725601 PURPOSE OF THE NFP DEVELOP RESEARCH AND CLINICAL INVESTIGATION. CLINICAL TRIALS 339,961 FEDERAL GRANTS 189,007 CLINICAL RESEARCH 1,196,633 1304150 11029 DEVELOP CLINICAL INVESTIGATION AND RESEARCH. 1304150 11029 1304150 true false false false false false false false false false true false false false true false true false false false false false false false false false false false false true false false false false false false false false false false false false false false false false false false 0 0 false 18 false false false false false false false false false X 7 7 false false false false false false false true true false false false false true true true true false PUERTO RICO CONSORTIUM FOR CLINICAL INVESTIGATION 7875231592 105 ROAD NO 21 MONACILLOS SAN JUAN PR 00927 AMARILYS SIVA BOSCHETTI EXECUTIVE DI 40.00 X 184099 0 16500 RICARDO GARCIA TOLEDO FINANCIAL LE 40.00 X X 87149 0 3987 JORGE MARTINEZ CLINICAL RES 40.00 X X 66364 0 10370 DAYANARA BELEN SILVA BUSINESS DEV 40.00 X X 71469 0 3361 ZULMARIE VAZQUEZ GRANT PROJEC 40.00 X X 64800 0 1799 EDMAGALLY VILLAFANE RESEARCH QUA 40.00 X X 64800 0 1799 CHRISTIAN RAMIREZ OP PROJECT M 40.00 X X 24623 0 761 LCDA TERIC BRITO COMP MANAGER 40.00 X X 23056 0 713 586360 39290 1 true true false PR MEDICAL RESEARCH CENTER SUITE 401 PONCE DE LEON 735 HATOR REY SAN JUAN PR 00917 RESEARCH FACILI 172334 1 189007 1196633 1385640 CLINICAL TRIALS REVENUE 339961 339961 OTHER REVENUE 11029 11029 350990 1736630 350990 786616 494346 292270 423278 277586 145692 240419 218714 21705 6498 6498 28695 28695 17164 13702 3462 OTHER OPERATING EXP 127904 126499 1405 PROMOTION AND AWARENESS 62920 62872 48 REPAIR AND MAINTENANCE 42360 42360 TRAINING EXPENSES 32166 6188 25978 30576 26690 3886 1798596 1304150 494446 0 287324 252296 258640 287478 234175 161544 101326 72631 10140 9600 657430 622005 157902 164842 83455 103056 241357 267898 X 416073 354107 416073 354107 657430 622005 -61966 X false true X true false X 1117484 1062595 1178271 1433687 1385640 6177677 1117484 1062595 1178271 1433687 1385640 6177677 6177677 207476 136124 137902 119969 350990 952461 7130138 1570098 0.86640 0.84340 X true false PART II, LINE 10 OTHER INCOME 952,461 184668 129306 55362 49507 32238 17269 72631 LONG-TERM LIABILITIES 103056 103056 1736630 1736630 1736630 1798596 1798596 1798596 false false false false false false false false false AMARILYS SIVA BOSCHETTI EXECUTIVE DIRECTOR 184099 16500 200599 FORM 990, PAGE 2, PART III, LINE 4D DEVELOP CLINICAL INVESTIGATION AND RESEARCH. FORM 990, PAGE 6, PART VI, LINE 11B THE RETURN IS PREPARED BY RSM PUERTO RICO EXTERNAL AUDITORS AND TAX ADVISORS INFORMATION REPORTED IN THE RETURN IS PROVIDED BY MANAGEMENT OF PUERTO RICO SCIENCE CONSORTIUM FOR CLINICAL INVESTIGATION. DURING THE PREPARATION OF THE RETURN RSM PUERTO RICO AND MANAGEMENT ARE IN CONSTANT COMMUNICATION SHARING AND CONFIRMING THE INFORMATION IN THE RETURN. WHEN COMPLETED THE RETURN IS PROVIDED TO THE ORGANIZATIONS ACCOUNTING DIRECTOR FOR FINAL REVIEW PRIOR TO FILING. THE PUERTO RICO CONSORTIUM FOR CLINICAL INVESTIGATION, INC. (PRCCI), A PUERTO RICO NOT-FORPROFIT ORGANIZATION, WAS ORGANIZED ON JANUARY 20, 2016 AS A WHOLLY-OWNED SUBSIDIARY OF PUERTO SCIENCE, TECHNOLOGY AND RESEARCH TRUST (THE PARENT COMPANY). PRCCI WAS ESTABLISHED BY VIRTUE OF ARTICLE 5 (26) OF ACT NO. 214 OF AUGUST 18, 2004, AS AMENDED. PRCCI BEGAN OPERATIONS ON APRIL 1, 2016, AND ITS PURPOSE IS TO IMPROVE THE IMPACT, QUALITY, AND SPEED OF CLINICAL RESEARCH ACTIVITY CONDUCTED IN PUERTO RICO, ESPECIALLY IN THE FIELDS OF ONCOLOGY, INFECTIOUS DISEASES, NEUROLOGICAL DISORDERS AND CARDIO-METABOLISM. TO ACHIEVE ITS MISSION, PRCCI HAS PARTNERS WITH CLINICAL RESEARCH SITES ACROSS PUERTO RICO TO ENSURE ACCESS TO A DIVERSE PATIENT POPULATION. PRCCL'S OPERATIONS ARE SUSTAINED THROUGH A COMBINATION OF REVENUES OBTAINED FROM CLINICAL RESEARCH, GRANTS AND CONTRACTS WITH FEDERAL, STATE AND PRIVATE ENTITIES, AND CONTRIBUTIONS FROM THE PARENT COMPANY. FORM 990, PAGE 6, PART VI, LINE 15A COMPENSATION IS REVIEWED AND APPROVED BY PRST. FORM 990, PAGE 6, PART VI, LINE 15B COMPENSATION IS REVIEWED AND APPROVED BY PRST. FORM 990, PAGE 6, PART VI, LINE 19 NO DOCUMENTS AVAILABLE TO THE PUBLIC